Wedge Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-70,736
Closed -$2.54M 563
2019
Q4
$2.54M Buy
70,736
+46,512
+192% +$1.61M 0.03% 283
2019
Q3
$828K Hold
24,224
0.01% 350
2019
Q2
$678K Sell
24,224
-42,060
-63% -$1.17M 0.01% 404
2019
Q1
$2.06M Buy
66,284
+23,009
+53% +$614K 0.02% 287
2018
Q4
$1.02M Buy
43,275
+2,675
+7% +$73.1K 0.01% 334
2018
Q3
$1.57M Hold
40,600
0.02% 303
2018
Q2
$1.36M Hold
40,600
0.01% 321
2018
Q1
$1.47M Sell
40,600
-1,200
-3% -$41.6K 0.01% 298
2017
Q4
$1.33M Hold
41,800
0.01% 322
2017
Q3
$1.56M Hold
41,800
0.01% 296
2017
Q2
$1.3M Sell
41,800
-10,000
-19% -$289K 0.01% 302
2017
Q1
$1.28M Sell
51,800
-1,300
-2% -$30.5K 0.01% 296
2016
Q4
$1.35M Sell
53,100
-11,600
-18% -$257K 0.01% 291
2016
Q3
$1.28M Buy
64,700
+12,700
+24% +$222K 0.01% 290
2016
Q2
$742K Buy
52,000
+34,641
+200% +$530K 0.01% 363
2016
Q1
$269K Buy
+17,359
New +$249K ﹤0.01% 530

Other funds holding LMAT

Wedge Capital Management's LMAT Position: Q1 2020 in Review

Wedge Capital Management sold out of LeMaitre Vascular (LMAT) in Q1 2020, closing a stake of 70,736 shares — an estimated $2.54M sold.

Wedge Capital Management first reported a position in LMAT in Q1 2016 and held it in 16 quarters. The position peaked at $2.54M in Q4 2019. 144 funds tracked by Wall St. Rank hold LMAT as of Q1 2020.

  • Wedge Capital Management reported no remaining LeMaitre Vascular position as of Q1 2020 after selling out during the quarter.
  • Wedge Capital Management sold 70,736 LeMaitre Vascular shares in Q1 2020, an estimated $2.54M.
  • Wedge Capital Management first reported a position in LeMaitre Vascular in Q1 2016 and held it in 16 quarters.
  • Wedge Capital Management's LeMaitre Vascular position peaked at $2.54M in Q4 2019.
  • 144 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2020.

Based on Wedge Capital Management's 13F filing for Q1 2020, filed 13 Apr 2020.